Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assays
双吲哚马来酰亚胺 IX：一种针对病毒主蛋白酶 3CLpro 的新型抗 SARS-CoV2 药物，通过虚拟筛选流程和体外验证试验证明
期刊:Methods
影响因子:4.2
doi:10.1016/j.ymeth.2021.01.003
Yash Gupta, Dawid Maciorowski, Samantha E Zak, Krysten A Jones, Rahul S Kathayat, Saara-Anne Azizi, Raman Mathur, Catherine M Pearce, David J Ilc, Hamza Husein, Andrew S Herbert, Ajay Bharti, Brijesh Rathi, Ravi Durvasula, Daniel P Becker, Bryan C Dickinson, John M Dye, Prakasha Kempaiah
